NextGen Healthcare Solutions
Bound Therapeutics, LLC
HOME
(current)
ABOUT
Leadership
Scientific Advisers
Business Advisers
Partnerships
SCIENCE
MicroRNA Platform Technology
Program & Pipeline
Publications
INVESTORS
Business Model
Intellectual Property
NEWS & MEDIA
Press Release
Events & Presentations
CONTACT
Issued and Pending IP
New patent application will be filed for each new composition of matter agent discovered:
Compositions and methods for MYC messenger RNA inhibitors. (PCT/US2018/049055).